<DOC>
	<DOC>NCT00947128</DOC>
	<brief_summary>To demonstrate the relative bioavailability study of Ondansetron HCl 24 mg tablets under non-fasting conditions.</brief_summary>
	<brief_title>To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening. Positive test results for HIV or hepatitis B or C. Treatment for drug or alcohol dependence.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>58 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Antiemetic</keyword>
</DOC>